Biology subjects

Dakhili, S. Y. T.

Publications and source records attributed to Dakhili, S. Y. T..

2 recordsLinked to original sources

bioRxiv2025

Structural Divergence without Functional Impact: Comparative Characterization of SARS-CoV-2 3CL-Mpro Variants Using Cleavage Site Substrates

The SARS-CoV-2 main protease (3CLpro) is essential for viral replication and a leading antiviral target. Circulating variants accumulate substitutions on this enzyme, distant from the catalytic site. Surprisingly, mutant enzymes retain full proteolytic activity, though preserved overall activity does not exclude subtler effects on substrate recognition or selectivity, arising from distal structural perturbations. In this study, we compared the steady-state kinetics of wild-type (Wuhan) 3CLpro with enzymes from the Beta (K90R), Lambda (G15S), and Omicron (P132H) variants, using two peptide substrates representing distinct viral polyprotein cleavage sites. All four proteases displayed comparable catalytic efficiencies, similar pH-rate profiles, suggesting conservation of the catalytic mechanism despite sequence variation. The crystal structure of Omicron 3CLpro bound to an Nsp8-Nsp9 peptide revealed a conserved fold and active-site geometry, with the P132H side chain adopting a substrate-dependent conformation that rebuilt its local contacts, indicating towards how a distal substitution is accommodated without perturbing catalysis. Thermal stability measurements identified the sole distinguishing effect of P132H, with Omicron showing altered stability at elevated temperature. A screen of 31 tanshinones against 3CLpro identified T06 with Ki values of 5 uM, as 3CL pro inhibitor. Thus, 3CLpro may tolerate distal substitutions through local structural adaptation, supporting its durability as an antiviral target.

biochemistry↗

bioRxiv2025

Beyond Degradation: How Reverse Proteolysis Creates Disease-Relevant Antigens

Proteases are conventionally regarded as degradative enzymes, yet their catalytic machinery also permits peptide bond formation through reverse proteolysis, a process that remains poorly characterized. Here, we show that lysosomal cysteine cathepsins catalyze iterative cycles of hydrolysis and ligation to generate multi-generational fusion peptides, including hybrids derived from host-viral protein substrates. Quantitative analysis demonstrates that peptide ligation can account for up to 4.5% of proteolytic turnover. This activity is strongly influenced by pH, substrate sequence, and post-translational modification, with citrullination and neutral pH favoring fusion peptide formation and the accumulation of more stable higher-order products. Using full-length protein substrates, we provide direct evidence that cathepsins can generate a hybrid insulin peptide previously identified as a Type 1 Diabetes (TID) autoantigen in patients. Moreover, several identified fusion peptides show effective binding to TID-associated HLA class II molecules. To examine whether ligation products can be captured under cellular conditions, we developed a click-based targeted transpeptide retrieval and purification strategy (CT-TRAP), which enabled detection of probe-derived cis/transpeptides in cell-based systems under controlled conditions. These findings establish reverse proteolysis by cysteine cathepsins as a quantifiable enzymatic pathway for generating non-genomically templated peptides, revealing an unrecognized dimension of lysosomal protease activity and peptide diversification.

biochemistry↗